M-14009 Prostate-Specific Antigen (PSA) Quantitative Test Kit

Clinical Significance: Serum PSA measurement is highly accurate, stable, and reproducible, making it a non-invasive method that aids in the early diagnosis of prostate cancer, monitoring treatment response, and assessing prognosis. It can also be used for screening high-risk populations (men over 50 years old) for prostate cancer. When combined with clinical examination, PSA significantly enhances the diagnosis of prostate cancer, a fact that is widely recognized.
Product Specifications: 20 tests per box
Product Shelf Life: Sealed in an aluminum foil bag, the product is valid for 18 months. Once opened, the aluminum foil bag should be used within 1 hour.
Product Storage: Store the test cards at 2°C to 30°C.
 
Usage Scenarios:
Hospitals and Urology Departments: For early diagnosis, monitoring treatment response, and assessing prognosis of prostate cancer.
Primary Care and Screening Programs: For routine screening of high-risk populations, particularly men over 50 years old, to detect prostate cancer early.
Diagnostic Laboratories: For routine testing of serum PSA levels to aid in the diagnosis and management of prostate cancer.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where comprehensive cancer screening programs and advanced diagnostic tools are widely available.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are improving cancer diagnostic capabilities and expanding access to early detection tools.
Global Health Programs: International health initiatives focused on enhancing cancer screening and management in low-resource settings.